RamonEdgarParsonsMDPhD

Chair of Oncological Sciences at the Icahn School of Medicine at Mount Sinai

Dr. Parsons is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Stony Brook University Health Sciences Center School of MedicineClass of 1992, MD

PubMed

32 citations
Design, Synthesis, and Evaluation of Potent, Selective, and Bioavailable AKT Kinase Degraders.
Xufen Yu, Jia Xu, Ling Xie, Li Wang, Yudao Shen
Journal of Medicinal Chemistry. 2021-12-02
33 citations
AKT Degradation Selectively Inhibits the Growth of PI3K/PTEN Pathway-Mutant Cancers with Wild-Type KRAS and BRAF by Destabilizing Aurora Kinase B.
Jia Xu, Xufen Yu, Tiphaine Martin, Ankita Bansal, Kakit Cheung
Cancer Discovery. 2021-07-23
17 citations
NOTCH and EZH2 collaborate to repress PTEN expression in breast cancer.
Kyrie Pappas, Tiphaine Martin, Andrew Wolfe, Christie B. Nguyen, Tao Su
Communications Biology. 2021-03-09

Journal Articles

Mouse ER+/PIK3CAH1047R Breast Cancers Caused by Exogenous Estrogen Are Heterogeneously Dependent on Estrogen and Undergo BIM-Dependent Apoptosis with BH3 and PI3K Agents
Matthias Szabolcs, Ramon Parsons, Hank Schmidt, Nature

Two Renowned Cancer Experts to Head New Tisch Cancer Hospital at the Mount Sinai HospitalMarch 15th, 2023
Newly Developed Therapeutic Agent Can Be Effective for Various Cancer TypesJanuary 26th, 2023
New Gene Essential to Colon Cancer Growth IdentifiedOctober 18th, 2022
Join now to see all

Mutual Regulation Of PTEN And P-Rex2a In Normal And Cancer CellsNational Cancer Institute2011–2012
Oncogenic Role Of PIK3CA Hotspot MutationsNational Cancer Institute2009–2012
The Role Of PTEN In Basal-Like Breast CancerNational Cancer Institute2011
Administrative And Analytical CoreNational Cancer Institute2011
Molecular Pathogenesis Of Basal-Like Breast CancerNational Cancer Institute2009–2011
Breast Cancer ResearchNational Cancer Institute2008–2011
PTEN Tumor Suppressor And Signal TransductionNational Cancer Institute2001–2010
PI-3 Kinase Therapy In Mouse Tumor ModelsNational Cancer Institute2002–2005
Characterization Of The 10q22-23 Candidate Tumor Suppressor In Breast CancerNational Cancer Institute1998–2001
Colorectal Specific Gene ExpressionNational Cancer Institute1992–1994